Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
RGC: Regencell Bioscience Holdings Limited Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
RGC
The Story
RGC
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-444.2%
Financially safe
Stretched
Debt / equity
0.32×
Interest coverage
0.0×
Current ratio
1.42×
Regencell Bioscience Holdings Limited
RGC
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Regencell Bioscience Holdings Limited
RGC
NASDAQ
·
USD
·
Closed
$6.18
+4.04%
$6.18
+$0.24 (4.04%)
52W Range
3th
pctl
Volume
0.67×
avg
Mkt Cap
3.06B
USD
P/E
-435.2
TTM
Div Yield
–
ann
52W Range
3th
pctl
Volume
0.67×
avg
Market Cap
3.06B
USD
P/E Ratio
-435.2
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings